iBio Enters Into $10 Million Common Stock Purchase Agreement With Aspire …
MarketWatch After the SEC declares a registration statement effective relating to the transaction, Aspire Capital has committed to purchase up to $9.5 million in additional shares of common stock over a 24 month period. No warrants are associated with this agreement. |